UPDATE: Apama Medical raises $20m

Updated to include new information from Apama Medical Novel catheter ablation tech developer Apama Medical said it raised a total of $19.7 million, with $13.2 million coming from a closed Series C round and $6.5 million from a debt facility with Silicon Valley Bank. Apama Medical is developing novel ablation catheter technology to combine “the best elements of existing ablation technology while incorporating additional unique features to address gaps in current technology,” according to it’s website. The Series C round was joined by Ascension Ventures, Medvance Incubator Partners, ONSET Ventures, Incept and various angel investors, the company said. “We are pleased to receive such strong support from our existing investors, which we attribute to the tremendous progress of the company, including the initiation of our AF-Ficient FIH clinical study earlier this year,” CEO Amr Salahieh said in a press release. A total of 63 investors took part in the round, according to an SEC filing; the company hopes to raise another $313,496 before closing it. Apama Medical said its new device aims to reduce procedure time due to “multipoint, single-shot design” and optimized placement via real-time visualization. Apama said the device design will include the ability to create customizable lesion patterns to allow for the treatment of various AF types. The Campbell, Calif.-based company said it recently released results from the AF-Ficient FIH clinical...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Catheters Funding Roundup Wall Street Beat Apama Medical Source Type: news